PMED logo

PEPTONIC medical AB (publ) Stock Price

NGM:PMED Community·SEK 92.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

PMED Share Price Performance

SEK 0
0.00 (0.00%)
SEK 0
0.00 (0.00%)
Price SEK 0

PMED Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

5 Risks
0 Rewards

PEPTONIC medical AB (publ) Key Details

SEK 40.5m

Revenue

SEK 20.5m

Cost of Revenue

SEK 20.0m

Gross Profit

SEK 51.0m

Other Expenses

-SEK 31.0m

Earnings

Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
May 07, 2024
-0.02
49.35%
-76.50%
6.7%
View Full Analysis

About PMED

Founded
2009
Employees
32
CEO
Anna Linton
WebsiteView website
www.peptonicmedical.se

PEPTONIC medical AB (publ), a pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health. It offers VagiVital, a hormone-free treatment for symptoms related to vaginal atrophy, such as pain during intercourse, burning, itching, and dryness, as well as moisturizing and an oil-based intimate wash. The company also provides lifestyle consumer products under the Lunette brand. PEPTONIC medical AB (publ) was incorporated in 2009 and is headquartered in Bromma, Sweden.

Recent PMED News & Updates

Recent updates

No updates